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THE NEED FOR HARM REDUCTION
 In 2019 there were 96 fatal overdoses in Vermont 
(prelim)
 86% of those overdoses involved fentanyl
 People engaged in medication-assisted treatment (MAT) 
have lower mortality rate than those untreated 
 People in MAT are better connected to other 
prevention resources
 576 community-distributed naloxone kits were used to 
reverse perceived overdose (2019, preliminary Q1-Q3)
 In a VT questionnaire, >50% of participants said that 
they had never heard of fentanyl test strips and would 
use them if they had them
Harm reduction: 
1. A set of practical strategies and ideas aimed at reducing 
negative consequences associated with drug use.
2. A movement for social justice built on a belief in, and 
respect for, the rights of people who use drugs.
PUBLIC HEALTH COST AND 
COMMUNITY CONSIDERATIONS
 It is estimated that opiate use disorder (OUD) costs the 
Medicaid system > $8 billion per year
 Costs society > $78 billion per year
 These costs have been rising over the past several years
 People with OUD seek more medical treatment, have longer 
inpatient stays, require more interventions
 Lives of friends, family, neighbors, co-workers
COMMUNITY PERSPECTIVE AND SUPPORT
 Javad Mashkuri, MD is a physician in the CVMC ED. He 
pioneered rapid access to MAT (RAM) in the CVMC ED. 
He identified the need in our community and our ED 
for better treatment for OUD. He is passionate about 
meeting people where they’re at, no matter where they 
are in their recovery. He feels strongly that addiction is 
a disease and should be treated as so. He acknowledges 
that people struggling with addiction have often been 
mistreated, especially by the medical field. He wants 
people to know that the ED is somewhere that they are 
always welcome.
 Laurie Hanson is MAT nurse at CVMC. She sees the 
need for naloxone in remote Vermont locations that are 
far from emergency medical services and is excited to 
see its impact. 
 Theresa Vezina works for Vermont Cares, a non-
profit focused on prevention, welling being, and 
harm reduction. She is passionate about all things 
harm reduction. She really listens to clients when 
she meets with them and works with them to 
meet their needs. She believes that ”a harm 
reduction philosophy could be implemented in all 
sectors of social and health services. “ She would 
love to see “expanded access in less stigmatizing 
settings,” “harm reduction interventions for non-
injecting persons,” and “more support for 
families to teach them about harm reduction.”
INTERVENTION/METHODOLOGY
 Production and distribution of harm reduction kits
 Supplies: Narcan, fentanyl test strips, sterile water, condoms, 
alcohol swab, gloves
 Literature surrounding: safer use, local resources, overdose 
awareness and response, how to use fentanyl strips
 Harm reduction training for recovery coaches
 Harm reduction training for nursing staff in the Emergency 
Department
 Collaborative effort with Washington County Substance 
Abuse Partnership (WCSAP) and CVMC MAT team
RESULTS/RESPONSE
 Increased awareness among ED and Turning Point staff 
of harm reduction definition, implementation, and local 
resources
 Availability of harm reduction kits to patients in the 
ED and CVMC Madriver MAT
 Increased community awareness of safer use practices 
and local resources and treatment option
 Community members who are more informed and 
better equipped to keep themselves healthy 
 (Hopeful) More members of our community living 
longer healthier lives 
EFFECTIVENESS/LIMITATIONS
Ways to measure effect:
 Qualitative evaluation by feedback of harm reduction 
kit recipients 
 Qualitative feedback from recovery coaches and 
nursing staff
 Quantitative evaluation comparing  drug-associated 
ED admissions and medical interactions before and 
after implementation
 Quantitative evaluation by incorporating intake 
inquiry at VT Cares and other local treatment 
centers
Limitations:
 In early stages of distribution
 Difficult group of patients to follow
 Multiple reasons for seeking medical care related to 
drug use
 Could hinder therapeutic relationships by over-
polling
RECOMMENDATIONS FOR FUTURE INTERVENTION/PROJECT
 Widening distribution of harm reduction kits to more CVMC sites 
 Widening harm reduction education to other CVMC sites
 Data collection surrounding use of fentanyl strips, Narcan, and other harm reduction items
 Comparison of pre-administration drug-related healthcare visits and post-administrative visits
 Tracking behavior change following harm reduction kit acquisition 
 Chart review of most common drug-related medical problems within our network
 Implementation of syringe service
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